Keytruda has recently come into focus in India as discussions around advanced cancer treatment and affordability gain momentum. The drug is widely used globally and is now being talked about more активно in the context of India’s fight against cancer.
What Is Keytruda?
Keytruda (generic name: pembrolizumab) is an immunotherapy drug developed by Merck & Co.. Unlike traditional chemotherapy, it works by helping the body’s immune system identify and attack cancer cells more effectively.
It is used to treat several types of cancers, including lung cancer, melanoma and certain head and neck cancers.
Why Is It Trending In India?
The drug has become a major talking point due to its high cost and increasing demand. In India, access to advanced cancer therapies remains a challenge, and Keytruda is often seen as a breakthrough yet expensive option.
Recent discussions have centred around making such life-saving treatments more affordable and widely available to patients.
How Does It Work?
Keytruda belongs to a class of drugs known as immune checkpoint inhibitors. It blocks a specific protein that prevents the immune system from attacking cancer cells, thereby enabling the body to fight the disease more effectively.
Benefits And Limitations
Studies have shown that the drug can significantly improve survival rates in some patients. However, it is not suitable for everyone and can have side effects like fatigue, skin reactions and immune-related complications.
Doctors emphasise that treatment must be personalised based on the patient’s condition.
Cost And Accessibility Debate
One of the biggest concerns in India is affordability. The high price of Keytruda has sparked debate over pricing policies and access to advanced medicines.
Experts believe that policy interventions and generic alternatives could help make such treatments more accessible.
Final Take
Keytruda represents a significant advancement in cancer care. However, its growing popularity in India also highlights the urgent need to balance innovation with affordability, ensuring that more patients can benefit from modern treatments.
Read more trending news here
